The hunt for efficient, incomplete designs for stepped wedge trials with continuous recruitment and continuous outcome measures.

Algorithms Cluster randomised trials Continuous recruitment Efficient design Stepped wedge trials

Journal

BMC medical research methodology
ISSN: 1471-2288
Titre abrégé: BMC Med Res Methodol
Pays: England
ID NLM: 100968545

Informations de publication

Date de publication:
17 11 2020
Historique:
received: 29 05 2020
accepted: 30 10 2020
entrez: 18 11 2020
pubmed: 19 11 2020
medline: 25 6 2021
Statut: epublish

Résumé

We consider the design of stepped wedge trials with continuous recruitment and continuous outcome measures. Suppose we recruit from a fixed number of clusters where eligible participants present continuously, and suppose we have fine control over when each cluster crosses to the intervention. Suppose also that we want to minimise the number of participants, leading us to consider "incomplete" designs (i.e. without full recruitment). How can we schedule recruitment and cross-over at different clusters to recruit efficiently while achieving good precision? The large number of possible designs can make exhaustive searches impractical. Instead we consider an algorithm using iterative improvements to hunt for an efficient design. At each iteration (starting from a complete design) a single participant - the one with the smallest impact on precision - is removed, and small changes preserving total sample size are made until no further improvement in precision can be found. Striking patterns emerge. Solutions typically focus recruitment and cross-over on the leading diagonal of the cluster-by-time diagram, but in some scenarios clusters form distinct phases resembling before-and-after designs. There is much to be learned about optimal design for incomplete stepped wedge trials. Algorithmic searches could offer a practical approach to trial design in complex settings generally.

Sections du résumé

BACKGROUND
We consider the design of stepped wedge trials with continuous recruitment and continuous outcome measures. Suppose we recruit from a fixed number of clusters where eligible participants present continuously, and suppose we have fine control over when each cluster crosses to the intervention. Suppose also that we want to minimise the number of participants, leading us to consider "incomplete" designs (i.e. without full recruitment). How can we schedule recruitment and cross-over at different clusters to recruit efficiently while achieving good precision?
METHODS
The large number of possible designs can make exhaustive searches impractical. Instead we consider an algorithm using iterative improvements to hunt for an efficient design. At each iteration (starting from a complete design) a single participant - the one with the smallest impact on precision - is removed, and small changes preserving total sample size are made until no further improvement in precision can be found.
RESULTS
Striking patterns emerge. Solutions typically focus recruitment and cross-over on the leading diagonal of the cluster-by-time diagram, but in some scenarios clusters form distinct phases resembling before-and-after designs.
CONCLUSIONS
There is much to be learned about optimal design for incomplete stepped wedge trials. Algorithmic searches could offer a practical approach to trial design in complex settings generally.

Identifiants

pubmed: 33203361
doi: 10.1186/s12874-020-01155-z
pii: 10.1186/s12874-020-01155-z
pmc: PMC7672921
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

279

Subventions

Organisme : National Health and Medical Research Council (Australia)
ID : 1108283
Pays : International

Références

Stat Med. 2019 Mar 30;38(7):1103-1119
pubmed: 30402914
Stat Med. 2020 Mar 30;39(7):815-844
pubmed: 31876979
Stat Med. 2016 Nov 20;35(26):4718-4728
pubmed: 27350420
Stat Med. 2019 Jan 30;38(2):184-191
pubmed: 30209821
BMJ. 2015 Jun 08;350:h2925
pubmed: 26055828
Stat Methods Med Res. 2019 Mar;28(3):703-716
pubmed: 29027505
Stat Med. 2016 Jun 15;35(13):2149-66
pubmed: 26748662
Trials. 2016 Aug 15;17:402
pubmed: 27524396
BMJ. 2018 Nov 9;363:k1614
pubmed: 30413417
Stat Med. 2019 May 20;38(11):1918-1934
pubmed: 30663132
Stat Med. 2019 Nov 10;38(25):5021-5033
pubmed: 31475383
Trials. 2016 Sep 06;17(1):438
pubmed: 27600609
Contemp Clin Trials. 2007 Feb;28(2):182-91
pubmed: 16829207
Stat Med. 2019 Oct 15;38(23):4686-4701
pubmed: 31321806
Biometrics. 2019 Mar;75(1):144-152
pubmed: 30051909
J Clin Epidemiol. 2019 Dec;116:161-166
pubmed: 31272885
Stat Med. 2018 Jul 20;37(16):2487-2500
pubmed: 29635789
BMJ. 2015 Feb 06;350:h391
pubmed: 25662947

Auteurs

Richard Hooper (R)

Queen Mary University of London, London, UK. r.l.hooper@qmul.ac.uk.
Institute of Population Health Sciences, Yvonne Carter Building, 58 Turner Street, Whitechapel, London, E1 2AB, UK. r.l.hooper@qmul.ac.uk.

Jessica Kasza (J)

Monash University, Melbourne, Australia.

Andrew Forbes (A)

Monash University, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH